Joseph Marchionna
Papers
1
Total Citations
152
H-Index
1
About
Joseph Marchionna is a pioneering figure in solid-state chemistry and pharmaceutical materials science, best known for his transformative work in high-throughput crystallization and polymorphism. His research centers on the discovery, characterization, and control of crystalline forms of active pharmaceutical ingredients, with a particular emphasis on understanding how molecular packing influences stability and bioavailability. Marchionna’s most impactful contribution is the development of the CrystalMax platform, an integrated system combining design software, robotic sample handling, and high-throughput microanalytics. This innovation enabled the rapid, systematic exploration of crystallization conditions, dramatically accelerating the discovery of polymorphs. His landmark 2002 study on acetaminophen, which has garnered over 150 citations, exemplifies this approach: using CrystalMax, Marchionna and his team prepared and characterized three distinct crystal forms of the common painkiller, including the elusive Form III, whose structure was experimentally determined for the first time. This work not only demonstrated the power of automated screening but also provided critical insights into the thermodynamic relationships between polymorphs. Marchionna’s achievements have had lasting influence on pharmaceutical development, where controlling polymorphism is essential for ensuring drug efficacy, safety, and patent protection.
Research Focus
Key Achievements
Top Papers
- 1